Seeing Is Believing
Currently out of the existing stock ratings of James Terwilliger, 4 are a HOLD (22.22%), 14 are a BUY (77.78%).
Analyst James Terwilliger, carries an average stock price target met ratio of 50% that have a potential upside of 27.91% achieved within 316 days.
James Terwilliger’s has documented 38 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INFU, InfuSystems Holdings at 29-Dec-2021.
Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for CSII (CARDIOVASCULAR SYSTEMS) at 10/22/2013. The price target of $30 was fulfilled within 9 days with a profit of $3.25 (12.15%) receiving and performance score of 13.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25
$5 (25.00%)
$48
2 years 3 months 26 days ago
(14-Dec-2022)
4/8 (50%)
$10.95 (77.94%)
512
Hold
$18
$-2 (-10.00%)
$32
2 years 10 months 1 days ago
(08-Jun-2022)
3/4 (75%)
$2.82 (18.58%)
194
Buy
$20
$20
2 years 11 months 4 days ago
(05-May-2022)
12/13 (92.31%)
$4.32 (27.55%)
430
Buy
$34
$14 (70.00%)
$34
3 years 11 days ago
(29-Mar-2022)
1/5 (20%)
$11.85 (53.50%)
295
Hold
$49
3 years 4 months 22 days ago
(18-Nov-2021)
9/11 (81.82%)
$15.13 (44.67%)
234
What Year was the first public recommendation made by James Terwilliger?